Top Story

Total-body photography may reduce melanoma worry in patients with atypical mole syndrome

November 26, 2014

The use of total-body digital photography may reduce concerns about melanoma development among patients with atypical mole syndrome, according to study results.

Molly S. Moye, MD, of the department of dermatology at Emory University, and colleagues evaluated 138 patients seen at pigmented lesion clinics at Emory (n=93) and the University of Arizona (n=45).

Meeting News Coverage

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites even when they had…
In the Journals

Melanoma tumor genetics determined clinical benefit from CTLA-4 blockades

November 20, 2014
The presence of somatic neo-epitopes was associated with prolonged clinical benefit from CTLA-4 blockades in patients with melanoma, according to study results.High…
Dabrafenib–trametinib combination extended survival in metastatic melanoma In the Journals

Dabrafenib–trametinib combination extended survival in metastatic melanoma

November 17, 2014
The combination of dabrafenib and trametinib significantly extended OS compared with vemurafenib monotherapy in patients with treatment-naive metastatic melanoma who…
CME
Activity cover

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates

This activity is supported by an educational grant from Merck & Co., Inc.

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
In the Journals

Total-body photography may reduce melanoma worry in patients with atypical mole syndrome

November 26, 2014
The use of total-body digital photography may reduce concerns about melanoma development among patients with atypical mole syndrome, according to…
Meeting News Coverage

American Indians, Alaskan Natives experienced shorter cancer survival, even with equal access to care

November 21, 2014
Cancer survivors of American Indian or Alaskan Native descent demonstrated poorer rates of 5- and 10-year cancer survival than non-Hispanic whites…
In the Journals

Melanoma tumor genetics determined clinical benefit from CTLA-4 blockades

November 20, 2014
The presence of somatic neo-epitopes was associated with prolonged clinical benefit from CTLA-4 blockades in patients with melanoma, according to…
Dabrafenib–trametinib combination extended survival in metastatic melanoma In the Journals

Dabrafenib–trametinib combination extended survival in metastatic melanoma

November 17, 2014
The combination of dabrafenib and trametinib significantly extended OS compared with vemurafenib monotherapy in patients with treatment-naive…
In the Journals

Nivolumab superior to dacarbazine for untreated metastatic melanoma

November 16, 2014
Patients with treatment-naive, BRAF wild-type metastatic melanoma treated with nivolumab demonstrated longer OS and PFS than those treated with…
Final results of the MSLT-1 trial have added to data that support the role and value of sentinel lymph node biopsy in patients with melanoma, according to Vernon K. Sondak, MD, chair of cutaneous oncology at Moffitt Cancer Center and a HemOnc Today Editorial Board member. Cover StoryPublication Exclusive

Advances in melanoma prompt re-evaluation of SLN biopsy

HemOnc Today, November 10, 2014
Sentinel lymph node biopsy has long been the standard staging and prognostic modality for melanoma.Final results from the Multicenter Selective…
In the Journals

Immunosuppressants associated with modestly increased risk of malignancy

November 5, 2014
Patients with inflammatory eye disease who underwent systemic immunosuppressive therapy had a moderately higher risk of malignancy than those who…
In the Journals

Ipilimumab plus sargramostim prolonged OS, decreased toxicity in metastatic melanoma

November 4, 2014
The addition of sargramostim to ipilimumab significantly extended OS and decreased toxicity in patients with advanced melanoma, according to results…
In the Journals

Genetic determinant identified for increased melanoma risk

November 4, 2014
Genes associated with longer telomere length were linked to increased melanoma risk, according to study findings.Moreover, the researchers noted that…
In the Journals

Melanoma-prone families with CDKN2A mutations have higher rates of additional cancers

November 3, 2014
Researchers discovered an increased prevalence of lung, pancreatic and breast cancer in families prone to melanoma who also…
More Headlines »
morganatic-roan